Literature DB >> 29743594

Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo.

Aditya Parekh1, Subhayan Das1, Sheetal Parida1, Chandan Kanta Das1, Debabrata Dutta2, Sanjaya K Mallick3, Pei-Hsun Wu4, B N Prashanth Kumar1, Rashmi Bharti1, Goutam Dey1, Kacoli Banerjee1, Shashi Rajput1, Deblina Bharadwaj1, Ipsita Pal1, Kaushik Kumar Dey1, Yetirajam Rajesh1, Bikash Chandra Jena1, Angana Biswas1, Payel Banik1, Anjan K Pradhan5, Swadesh K Das5, Amit Kumar Das2, Santanu Dhara1, Paul B Fisher5, Denis Wirtz4, Gordon B Mills6, Mahitosh Mandal7.   

Abstract

Although there is a strong correlation between multinucleated cells (MNCs) and cancer chemo-resistance in variety of cancers, our understanding of how multinucleated cells modulate the tumor micro-environment is limited. We captured multinucleated cells from triple-negative chemo-resistant breast cancers cells in a time frame, where they do not proliferate but rather significantly regulate their micro-environment. We show that oxidatively stressed MNCs induce chemo-resistance in vitro and in vivo by secreting VEGF and MIF. These factors act through the RAS/MAPK pathway to induce chemo-resistance by upregulating anti-apoptotic proteins. In MNCs, elevated reactive oxygen species (ROS) stabilizes HIF-1α contributing to increase production of VEGF and MIF. Together the data indicate, that the ROS-HIF-1α signaling axis is very crucial in regulation of chemo-resistance by MNCs. Targeting ROS-HIF-1α in future may help to abrogate drug resistance in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29743594     DOI: 10.1038/s41388-018-0272-6

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  54 in total

1.  Signal transduction. A most interesting factor.

Authors:  R Bucala
Journal:  Nature       Date:  2000-11-09       Impact factor: 49.962

2.  A multistep model for paclitaxel-induced apoptosis in human breast cancer cell lines.

Authors:  A L Blajeski; T J Kottke; S H Kaufmann
Journal:  Exp Cell Res       Date:  2001-11-01       Impact factor: 3.905

Review 3.  Death through a tragedy: mitotic catastrophe.

Authors:  H Vakifahmetoglu; M Olsson; B Zhivotovsky
Journal:  Cell Death Differ       Date:  2008-04-11       Impact factor: 15.828

4.  Recurrent micronucleation through cell cycle progression in the presence of microtubule inhibitors.

Authors:  Yuji Nakayama; Narumi Uno; Katsuhiro Uno; Yamato Mizoguchi; Shinya Komoto; Yasuhiro Kazuki; Eiji Nanba; Toshiaki Inoue; Mitsuo Oshimura
Journal:  Cell Struct Funct       Date:  2015-01-09       Impact factor: 2.212

5.  Development of resistance to vincristine and doxorubicin in neuroblastoma alters malignant properties and induces additional karyotype changes: a preclinical model.

Authors:  Rouslan Kotchetkov; Jaroslav Cinatl; Roman Blaheta; Jens-Uwe Vogel; Jana Karaskova; Jeremy Squire; Pablo Hernáiz Driever; Thomas Klingebiel; Jindrich Cinatl
Journal:  Int J Cancer       Date:  2003-03-10       Impact factor: 7.396

6.  Reversine induces cell cycle arrest, polyploidy, and apoptosis in human breast cancer cells.

Authors:  Chin-Ho Kuo; Yin-Che Lu; Ya-Shin Tseng; Chung-Sheng Shi; Shu-Hsin Chen; Ping-Tzu Chen; Feng-Ling Wu; Yi-Ping Chang; Ying-Ray Lee
Journal:  Breast Cancer       Date:  2012-08-28       Impact factor: 4.239

Review 7.  The senescence-associated secretory phenotype: the dark side of tumor suppression.

Authors:  Jean-Philippe Coppé; Pierre-Yves Desprez; Ana Krtolica; Judith Campisi
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

Review 8.  ROS stress in cancer cells and therapeutic implications.

Authors:  Helene Pelicano; Dennis Carney; Peng Huang
Journal:  Drug Resist Updat       Date:  2004-04       Impact factor: 18.500

9.  Tumor cells can escape DNA-damaging cisplatin through DNA endoreduplication and reversible polyploidy.

Authors:  Pierre-Emmanuel Puig; Marie-Noëlle Guilly; André Bouchot; Nathalie Droin; Dominique Cathelin; Florence Bouyer; Laure Favier; François Ghiringhelli; Guido Kroemer; Eric Solary; François Martin; Bruno Chauffert
Journal:  Cell Biol Int       Date:  2008-05-02       Impact factor: 3.612

10.  Polyploidy Formation in Doxorubicin-Treated Cancer Cells Can Favor Escape from Senescence.

Authors:  Grazyna Mosieniak; Malgorzata A Sliwinska; Olga Alster; Anna Strzeszewska; Piotr Sunderland; Malgorzata Piechota; Halina Was; Ewa Sikora
Journal:  Neoplasia       Date:  2015-12       Impact factor: 5.715

View more
  21 in total

Review 1.  Neutrophils in the Tumor Microenvironment.

Authors:  Lingyun Wu; Sugandha Saxena; Rakesh K Singh
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 2.  Giants and monsters: Unexpected characters in the story of cancer recurrence.

Authors:  Shai White-Gilbertson; Christina Voelkel-Johnson
Journal:  Adv Cancer Res       Date:  2020-05-04       Impact factor: 6.242

3.  Genetic and pharmacological inhibition of acid ceramidase prevents asymmetric cell division by neosis.

Authors:  Shai White-Gilbertson; Ping Lu; James S Norris; Christina Voelkel-Johnson
Journal:  J Lipid Res       Date:  2019-04-15       Impact factor: 5.922

4.  Giant Y79 retinoblastoma cells contain functionally active T-type calcium channels.

Authors:  Sooyun Kim; Segundo Jose Guzman; Dong Hyun Jo; Chang Sik Cho; Jeong Hun Kim
Journal:  Pflugers Arch       Date:  2021-08-15       Impact factor: 4.458

5.  STAT1 potentiates oxidative stress revealing a targetable vulnerability that increases phenformin efficacy in breast cancer.

Authors:  Stephanie P Totten; Young Kyuen Im; Eduardo Cepeda Cañedo; Ouafa Najyb; Alice Nguyen; Steven Hébert; Ryuhjin Ahn; Kyle Lewis; Benjamin Lebeau; Rachel La Selva; Valérie Sabourin; Constanza Martínez; Paul Savage; Hellen Kuasne; Daina Avizonis; Nancy Santos Martínez; Catherine Chabot; Adriana Aguilar-Mahecha; Marie-Line Goulet; Matthew Dankner; Michael Witcher; Kevin Petrecca; Mark Basik; Michael Pollak; Ivan Topisirovic; Rongtuan Lin; Peter M Siegel; Claudia L Kleinman; Morag Park; Julie St-Pierre; Josie Ursini-Siegel
Journal:  Nat Commun       Date:  2021-06-03       Impact factor: 17.694

6.  VERU-111 suppresses tumor growth and metastatic phenotypes of cervical cancer cells through the activation of p53 signaling pathway.

Authors:  Vivek K Kashyap; Nirnoy Dan; Neeraj Chauhan; Qinghui Wang; Saini Setua; Prashanth K B Nagesh; Shabnam Malik; Vivek Batra; Murali M Yallapu; Duane D Miller; Wei Li; Bilal B Hafeez; Meena Jaggi; Subhash C Chauhan
Journal:  Cancer Lett       Date:  2019-12-03       Impact factor: 9.756

Review 7.  Polyploid giant cancer cell characterization: New frontiers in predicting response to chemotherapy in breast cancer.

Authors:  Geetanjali Saini; Shriya Joshi; Chakravarthy Garlapati; Hongxiao Li; Jun Kong; Jayashree Krishnamurthy; Michelle D Reid; Ritu Aneja
Journal:  Semin Cancer Biol       Date:  2021-03-22       Impact factor: 17.012

8.  Identification and Characterization of a New Platinum-Induced TP53 Mutation in MDAH Ovarian Cancer Cells.

Authors:  Ilaria Lorenzon; Ilenia Pellarin; Ilenia Pellizzari; Sara D'Andrea; Barbara Belletti; Maura Sonego; Gustavo Baldassarre; Monica Schiappacassi
Journal:  Cells       Date:  2019-12-21       Impact factor: 6.600

9.  The lack of functional DNMT2/TRDMT1 gene modulates cancer cell responses during drug-induced senescence.

Authors:  Dominika Bloniarz; Jagoda Adamczyk-Grochala; Anna Lewinska; Maciej Wnuk
Journal:  Aging (Albany NY)       Date:  2021-06-17       Impact factor: 5.682

10.  Tannic acid inhibits lipid metabolism and induce ROS in prostate cancer cells.

Authors:  Prashanth K B Nagesh; Pallabita Chowdhury; Elham Hatami; Shashi Jain; Nirnoy Dan; Vivek Kumar Kashyap; Subhash C Chauhan; Meena Jaggi; Murali M Yallapu
Journal:  Sci Rep       Date:  2020-01-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.